Toggle navigation
Home
Search
Services
Blog
Contact
About
Cancer & AIDS Drugs - Preclin Pharmacol/Toxicology
Page, J.
Southern Research Institute, Birmingham, AL, United States
Search 1132 grants from J. Page
Search grants from Southern Research Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The SMART-DAPPER study: Implementation research on Tele-mental health care in the COVID19 era
Nanoelectronic enabled chronic quantification of neurovascular coupling
Exome sequencing for head and neck cancer susceptibility genes
Prevention of hepatocellular carcinoma in vulnerable communities in Texas
Interaction between diet and genetic variation: influence on Type 2 Diabetes risk
Recently added grants:
Development of Next Generation Galeterone Analogs for Prostate Cancer Therapy
Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer
Defining the contributions of BRCA1, BRCA2, and RAD52 to genome stability
Targeting Oncogenic Ras-MAPK Signaling Complexes via the Scaffold KSR
Radiotherapy-associated breast cancer: machine learning on genotypes to predict individualized risk
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM037835-013
Application #
2300663
Study Section
Project Start
1993-01-01
Project End
1997-10-31
Budget Start
1996-09-30
Budget End
1996-10-31
Support Year
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Southern Research Institute
Department
Type
DUNS #
006900526
City
Birmingham
State
AL
Country
United States
Zip Code
35205
Related projects
Publications
Rodman, L E; Farnell, D R; Coyne, J M et al.
(1997)
Toxicity of cordycepin in combination with the adenosine deaminase inhibitor 2'-deoxycoformycin in beagle dogs.
Toxicol Appl Pharmacol 147:39-45
Comments
Be the first to comment on this grant